Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis
I Cordts, N Bodart, K Hartmann, K Karagiorgou… - Journal of …, 2017 - Springer
In autoimmune myasthenia gravis (MG), the identification of antibodies and characterization
of serological subgroups is of great importance for diagnosis and management of the …
of serological subgroups is of great importance for diagnosis and management of the …
[HTML][HTML] Clinical characteristics and prognosis of anti-AChR positive myasthenia gravis combined with anti-LRP4 or anti-titin antibody
Y Chen, X Tao, Y Wang, S Xu, Y Yang, J Han… - Frontiers in …, 2022 - frontiersin.org
Objective This study aimed to summarize the clinical characteristics and prognosis of
patients with anti-acetylcholine receptor (AChR) positive myasthenia gravis (MG) with a …
patients with anti-acetylcholine receptor (AChR) positive myasthenia gravis (MG) with a …
Multiple antibody detection in 'seronegative'myasthenia gravis patients
Y Hong, P Zisimopoulou, N Trakas… - European journal of …, 2017 - Wiley Online Library
Background and purpose Myasthenia gravis (MG) is an autoimmune disease caused by
antibody mediated impairment in the neuromuscular junction. Seronegative MG (SNMG) …
antibody mediated impairment in the neuromuscular junction. Seronegative MG (SNMG) …
Autoantibodies in myasthenia gravis
M Motomura - Brain and Nerve= Shinkei Kenkyu no Shinpo, 2013 - europepmc.org
Myasthenia gravis (MG) is caused by the failure of neuromuscular transmission mediated by
pathogenic autoantibodies (Abs). Generally, patients with MG are divided into 3 groups:(1) …
pathogenic autoantibodies (Abs). Generally, patients with MG are divided into 3 groups:(1) …
[HTML][HTML] Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics
K Lazaridis, SJ Tzartos - Frontiers in immunology, 2020 - frontiersin.org
Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and
fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by …
fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by …
[HTML][HTML] Serological diagnosis of myasthenia gravis and its clinical significance
Y Li, Y Peng, H Yang - Annals of Translational Medicine, 2023 - ncbi.nlm.nih.gov
Myasthenia gravis (MG) is the most common immune-mediated disorder of the
neuromuscular junction. Anti-acetylcholine receptor (anti-AChR), anti-muscle-specific kinase …
neuromuscular junction. Anti-acetylcholine receptor (anti-AChR), anti-muscle-specific kinase …
Autoantibodies to low-density lipoprotein receptor-related protein 4 in double seronegative myasthenia gravis: a systematic review
S Bacchi, P Kramer, C Chalk - Canadian Journal of Neurological …, 2018 - cambridge.org
Background: Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular
junction in which a clinical diagnosis may be confirmed with serological testing. The most …
junction in which a clinical diagnosis may be confirmed with serological testing. The most …
Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study
Introduction Our aim in this study was to identify the prevalence and clinical characteristics of
LRP4/agrin‐antibody–positive double‐seronegative myasthenia gravis (DNMG). Methods …
LRP4/agrin‐antibody–positive double‐seronegative myasthenia gravis (DNMG). Methods …
[HTML][HTML] Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with myasthenia gravis
M Marino, F Scuderi, D Samengo, G Saltelli, MT Maiuri… - PloS one, 2015 - journals.plos.org
Background Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients
have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while …
have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while …
Anti-LRP4 autoantibodies in AChR-and MuSK-antibody-negative myasthenia gravis
A Pevzner, B Schoser, K Peters, NC Cosma… - Journal of …, 2012 - Springer
Myasthenia gravis (MG) is an autoimmune disorder characterized by a defect in synaptic
transmission at the neuromuscular junction causing fluctuating muscle weakness with a …
transmission at the neuromuscular junction causing fluctuating muscle weakness with a …
相关搜索
- titin antibodies myasthenia gravis
- titin antibodies autoimmune spectrum
- myasthenia gravis autoimmune spectrum
- myasthenia gravis serological diagnosis
- myasthenia gravis clinical features
- myasthenia gravis italian patients
- myasthenia gravis cytofluorimetric analysis
- myasthenia gravis autoantibody specificities
- myasthenia gravis low density
- myasthenia gravis musk antibody
- myasthenia gravis clinical characteristics